Tim Dekker
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 9
- Oncology 10
- HER2/EGFR in Cancer Research 4
- CAR-T cell therapy research 2
- Co-authors
- Judith R. Kroep (13 shared papers)Wilma E. Mesker (17 shared papers)Vincent T.H.B.M. Smit (10 shared papers)Rob A.�E.�M. Tollenaar (12 shared papers)J.W.R. Nortier (2 shared papers)Saskia van de Ven (1 shared paper)Gabi W. van Pelt (3 shared papers)Cornelis J.�H. van de Velde (3 shared papers)
- Journals
- Annals of Oncology (4 papers)Breast Cancer Research and Treatment (4 papers)International Journal of Cancer (2 papers)Analytical and Bioanalytical Chemistry (1 paper)European Journal Of Haematology (1 paper)
- Partner nations
- NetherlandsGermanyBelgium
In The Last Decade
Tim Dekker
29 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 95
- Cancer Research 358
- Oncology 405
- Neurology 137
- Pathology and Forensic Medicine 122
- Spectroscopy 99
Countries citing papers authored by Tim Dekker
This map shows the geographic impact of Tim Dekker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Dekker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Dekker more than expected).
Fields of papers citing papers by Tim Dekker
This network shows the impact of papers produced by Tim Dekker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Dekker. The network helps show where Tim Dekker may publish in the future.
Co-authors
The 25 scholars most cited alongside Tim Dekker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 179 | |
| 2 | 2014 | 163 | |
| 3 | 2010 | 163 | |
| 4 | 2013 | 125 | |
| 5 | 2017 | 82 | |
| 6 | 2018 | 75 | |
| 7 | 2012 | 70 | |
| 8 | 2014 | 69 | |
| 9 | 2012 | 61 | |
| 10 | 2012 | 49 | |
| 11 | 2017 | 44 | |
| 12 | 2010 | 36 | |
| 13 | 2021 | 35 | |
| 14 | 2015 | 33 | |
| 15 | 2018 | 31 | |
| 16 | 2014 | 28 | |
| 17 | 2015 | 16 | |
| 18 | 2013 | 12 | |
| 19 | 2022 | 10 | |
| 20 | 2023 | 8 |
About Tim Dekker
Tim Dekker is a scholar working on Cancer Research, Oncology, Molecular Biology, Pathology and Forensic Medicine and Spectroscopy, having authored 30 papers that have together received 1.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), HER2/EGFR in Cancer Research (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Advanced Proteomics Techniques and Applications (2 papers), Neurofibromatosis and Schwannoma Cases (2 papers), Breast Lesions and Carcinomas (2 papers), CAR-T cell therapy research (2 papers) and Mass Spectrometry Techniques and Applications (2 papers). The work is most often cited by research in Cancer Research (358 citations), Oncology (405 citations), Neurology (137 citations), Pathology and Forensic Medicine (122 citations) and Spectroscopy (99 citations). Tim Dekker has collaborated with scholars based in Netherlands, Germany and Belgium. Frequent co-authors include Judith R. Kroep, Wilma E. Mesker, Vincent T.H.B.M. Smit, Rob A.�E.�M. Tollenaar, J.W.R. Nortier, Saskia van de Ven, Gabi W. van Pelt, Cornelis J.�H. van de Velde, Hans Gelderblom and Pancras C.W. Hogendoorn. Their work appears in journals such as Annals of Oncology, Breast Cancer Research and Treatment, International Journal of Cancer, Analytical and Bioanalytical Chemistry and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.